Effects of Social Housing Changes on Immunity and Vaccine-Specific Immune Responses in Adolescent Male Rhesus Macaques.
B cells
T cells
housing
immunity
measles
neutralizing antibodies
rhesus macaque
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2020
2020
Historique:
received:
26
05
2020
accepted:
24
09
2020
entrez:
12
11
2020
pubmed:
13
11
2020
medline:
18
5
2021
Statut:
epublish
Résumé
Nonhuman primates (NHPs) in research institutions may be housed in a variety of social settings, such as group housing, pair housing or single housing based on the needs of studies. Furthermore, housing may change over the course of studies. The effects of housing and changes in housing on cell activation and vaccine mediated immune responses are not well documented. We hypothesized that animals moved indoors from group to single housing (GH-SH) would experience more stress than those separated from groups into pair housing (GH-PH), or those placed briefly into pair housing and separated 5 weeks later into single housing (GH-PH-SH). We also compared the effects of separation from group to pair housing with the separation from pair to single housing. Eighteen male rhesus macaques were followed over the course of changes in housing condition over 10-14 weeks, as well as prior to and after primary vaccination with a commercially available measles vaccine. We identified two phenotypic biomarkers, namely total CD8 population and proliferating B cells, that differed significantly across treatment groups over time. At 10 weeks post-separation, levels of proliferating B cells were higher in GH-SH subjects compared to GH-PH subjects, and in the latter, levels were lower at 10 weeks than prior to removal from group housing. At 2 weeks post-separation from group to single housing, the frequency of CD8+ T cells was higher in GH-SH subjects compared to one week post separation from pair into single housing in the GH-PH-SH subjects. Comparing the same elapsed time since the most recent separation activated CD20 populations were persistently higher in the GH-SH animals than the GH-PH-SH animals. Housing configuration did not influence vaccine-mediated responses. Overall, our study found benefits of pair housing over single housing, suggesting that perturbations in immune function will be more severe following separation from group to single housing than from pair to single housing, and supporting the use of short-duration pair housing even when animals must subsequently be separated. These findings are useful for planning the housing configurations of research NHPs used for vaccine studies and other studies where immune response is being assessed.
Identifiants
pubmed: 33178191
doi: 10.3389/fimmu.2020.565746
pmc: PMC7593645
doi:
Substances chimiques
Measles Vaccine
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
565746Subventions
Organisme : NIH HHS
ID : P51 OD011104
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK109883
Pays : United States
Organisme : NIH HHS
ID : U42 OD024282
Pays : United States
Organisme : NIH HHS
ID : U42 OD010568
Pays : United States
Informations de copyright
Copyright © 2020 Pahar, Baker, Jay, Russell-Lodrigue, Srivastav, Aye, Blanchard and Bohm.
Références
J Virol. 2014 Aug;88(16):9442-57
pubmed: 24920807
Clin Transl Oncol. 2018 May;20(5):570-575
pubmed: 29058263
J Med Primatol. 2011 Apr;40(2):71-8
pubmed: 21371035
Clin Vaccine Immunol. 2008 Jul;15(7):1054-9
pubmed: 18463223
J Virol. 2014 Nov;88(22):13015-28
pubmed: 25165117
Virol J. 2012 Aug 13;9:160
pubmed: 22889373
Physiol Behav. 1993 Mar;53(3):599-602
pubmed: 8451329
Nat Rev Immunol. 2005 Mar;5(3):243-51
pubmed: 15738954
J Immunol Methods. 2003 Nov;282(1-2):103-15
pubmed: 14604545
J Immunol Methods. 2005 Sep;304(1-2):174-83
pubmed: 16129449
Virology. 1997 Jun 23;233(1):85-92
pubmed: 9229928
Vaccine. 2006 Nov 17;24(47-48):6839-49
pubmed: 17050045
Am J Primatol. 2013 Oct;75(10):995-1008
pubmed: 23640705
Virology. 1997 Jun 23;233(1):74-84
pubmed: 9201218
Viruses. 2016 Oct 12;8(10):
pubmed: 27754341
Viral Immunol. 2001;14(4):297-309
pubmed: 11792060
mBio. 2014 Apr 15;5(2):e01047
pubmed: 24736226
J Exp Med. 1989 Dec 1;170(6):2081-95
pubmed: 2531194
Comp Med. 2017 Dec 1;67(6):491-497
pubmed: 29212580
Am J Primatol. 2003 Oct;61(2):73-83
pubmed: 14582129
J Med Primatol. 1996 Jan;25(1):26-33
pubmed: 8740949
Physiol Behav. 1994 Apr;55(4):681-4
pubmed: 8190794
Physiol Behav. 1992 Mar;51(3):467-72
pubmed: 1523222
Am J Primatol. 1999;48(3):197-223
pubmed: 10380995
Neurosci Biobehav Rev. 2010 Sep;35(1):122-6
pubmed: 20083139
Eur J Immunol. 2006 Mar;36(3):583-92
pubmed: 16506292
Am J Primatol. 2017 Jan;79(1):1-14
pubmed: 26848542
Soc Neurosci. 2017 Feb;12(1):65-75
pubmed: 26801639
J Am Assoc Lab Anim Sci. 2013;52(3):240-6
pubmed: 23849405
J Infect Dis. 1990 Nov;162(5):1036-42
pubmed: 2230231
Lab Anim. 2012 Jan;46(1):51-8
pubmed: 22072624
J Neuroimmunol. 2012 Feb 29;243(1-2):34-42
pubmed: 22244573
Curr Opin Psychol. 2015 Oct 1;5:13-17
pubmed: 26086030
Am J Primatol. 2008 Jun;70(6):542-50
pubmed: 18189243
Viral Immunol. 2004;17(2):298-307
pubmed: 15279707
Comp Med. 2002 Oct;52(5):467-72
pubmed: 12405642
Brain Behav Immun. 2006 Mar;20(2):159-68
pubmed: 16102936
Clin Vaccine Immunol. 2006 Jan;13(1):45-52
pubmed: 16425999
Nat Med. 2000 Jul;6(7):776-81
pubmed: 10888926
Annu Rev Immunol. 2000;18:309-45
pubmed: 10837061
J Cell Physiol. 2000 Mar;182(3):311-22
pubmed: 10653597
Appl Anim Behav Sci. 2000 May 5;68(1):67-84
pubmed: 10771316
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4714-9
pubmed: 9539804
Am J Primatol. 2003 Jan;59(1):3-19
pubmed: 12526035
Am J Primatol. 2016 Jul;78(7):780-96
pubmed: 26971575